Angiotensinogen T235 expression is elevated in decidual spiral arteries

Journal of Clinical Investigation

Volumn 100, Issue 6, 1997, Pages 1406-1415

  Morgan, Terry ^a   Craven, Catherine ^c   Nelson, Lesa ^c   Lalouel, Jean Marc ^a,b   Ward, Kenneth ^a,c  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Allele specific expression; In situ RT PCR; Preeclampsia

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; DNA; MESSENGER RNA; NUCLEOTIDE;

ALLELE; ARTERY; ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN TISSUE; MUTATION; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030867545     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119661     Document Type: Article

References (55)

1. Page, E. 1939. The relation between hydatid moles, relative ischemia of the gravid uterus and placental origin of preeclampsia. Am. J. Obstet. Gynecol. 37:291.
2. Redman, C. 1991. Current topics: preeclampsia and the placenta. Placenta. 12:301-308.
3. Bulfin, M., and P. Lawler. 1957. Problems associated with toxemia in twin pregnancies. Am. J. Obstet. Gynecol. 73:37-42.
4. Roberts, J. 1989. Pregnancy related hypertension. In Maternal Fetal Medicine: Principles and Practice. R. Resnik. editor. W.B. Saunders Company, Philadelphia. 777-823.
5. Tenney, B. 1940. Placenta in toxemia of pregnancy. Am. J. Obstet. Gynecol. 39:1000-10005.
6. Schweikhart, G., P. Kaufmann, and T. Beck. 1986. Morphology of placental villi after premature delivery and its clinical relevance. Arch. Gynecol. 239:101-114.
7. Gant, N. 1976. Metabolic clearance rate of dehydroisoandrosterone sulfate VI. Studies of eclampsia. Obstet. Gynecol. 47:327-330.
8. Roberts, J., R. Taylor, T. Musci, G. Rodgers, C. Hubel, and M. McLaughlin. 1989. Preeclampsia: an endothelial cell disorder. Am. J. Obstet. Gynecol. 161:1200-1204.
9. Brosens, I., W. Robertson, and H. Dixon. 1967. The physiological response of the vessels of the placental bed to normal pregnancy. J. Pathol. Bacteriol. 93:569-579.
10. Zeek, P., and N. Assali. 1950. Vascular changes in the decidua associated with eclamptogenic toxemia. Am. J. Clin. Pathol. 20:1099.
11. Brosens, I., W. Robertson, and H. Dixon. 1972. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1:177-191.
12. Pijnenborg, R., J. Anthony, D. Davey, A. Rees, A. Tiltman, L. Vercruysse, and A. Assche. 1991. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br. J. Obstet. Gynaecol. 98:648-655.
13. Pijnenborg, R., G. Dixon, W. Robertson, and I. Brosens. 1980. Trophoblastic invasion of human decidua from 8 to 18 wks of pregnancy. Placenta. 1:3-19.
14. Pijnenborg, R., W. Robertson, I. Brosens, and G. Dixon. 1981. Trophoblast invasion and the establishment of hemochorial placentation in man and laboratory animals. Placenta. 2:71-92.
15. North, R., C. Ferrier, D. Long, K. Townend, and P. Kincaid-Smith. 1994. Uterine artery doppler flow velocity waveforms in the second trimester for the prediction of preeclampsia and fetal growth retardation. Obstet. Gynecol. 83:378-386.
16. Zamudio, S., S. Palmer, T. Dahms, J. Berman, D. Young, and L. Moore. 1995. Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude. J. Appl. Physiol. 79:15-22.
17. Nadji, P., and S. Sommers. 1973. Lesions of toxemia in first trimester pregnancies. Am. J. Clin. Pathol. 59:344-349.
18. Lichtig, C., M. Deutch, and J. Brandes. 1984. Vascular changes of endometrium in early pregnancy. Am. J. Clin. Pathol. 81:702-707.
19. Chesley, L., R. Cosgrove, and J. Annitto. 1961. Pregnancy in sisters and daughters of eclamptic women. Pathol. Microbiol 24:662-666.
20. Arngrimsson, R., H. Bjornsson, and R. Geirsson. 1995. Analysis of different inheritance patterns in preeclampsia/eclampsia syndrome. Hypertension in Pregnancy. 14:27-38.
21. Ward, K., A. Hata, X. Jeunemaitre, C. Helin, L. Nelson. C. Namikawa, P. Farrington, M. Ogasawara, K. Suzumori, S. Tomoda, et al. 1993. A molecular variant of angiotensinogen associated with preeclampsia. Nat. Genet. 4:59-61.
22. Arngrimsson, R., S. Purandare, M. Conner, J. Walke, S. Bjornssen, F. Soubrier, Y. Kotelevtsev, R. Geirsson, and H. Bjornsson. 1993. Angiotensinogen: a candidate gene involved in preeclampsia? Nat. Genet. 4:114-115.
23. Kobashi, G. 1995. A case-control study of pregnancy-induced hypertension with a genetic predisposition: association of a molecular variant of angiotensinogen in the Japanese women. Hok Ig Zasshi. 70:649-657.
24. Morgan, L., P. Baker, F.B. Pipkin, and N. Kalsheker. 1995. Pre-eclampsia and the angiotensin gene. Br. J. Obstet. Gynaecol. 102:489-490.
25. Inoue, I., T. Nakajima, C. Williams, J. Quackenbush, R. Puryear, M. Powers, T. Cheng, E. Ludwig, A. Sharma, A. Hata, et al. 1997. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99: 1786-1707.
26. Campbell, D. 1987. Circulating and Tissue Angiolensin Systems. J. Clin. Invest. 79:1-6.
27. Powell, J., J.-P. Clozel, R. Muller, H. Kuhn, F. Hefti, M. Hosang, and H. Baumbartner. 1989. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science (Wash. DC). 245:186-188.
28. Naftilian, A., W. Zuo, J. Ingelfinger, T. Ryan, R. Pratt, and V. Dzau. 1991. Localization and differential regulation of angiolensinogen mRNA expression in the vessel wall. J. Clin. Invest. 87:1300-1311.
29. Dzau, V. 1984. Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function. J. Cardiovas. Pharm. 6:377s-382s.
30. Berk, B., V. Vekshtein, H. Gordon, and T. Tsuda. 1989. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension (NY). 13:305-314.
31. Naftilan, A., R. Pratt, and V. Dzau. 1989. Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1419-1424.
32. Dzau, V., G. Gibbons, and R. Pratt. 1991. Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia. Hypertension (NY). 18:II100-II105.
33. Poulsen, K. 1973. Kinetics of the renin system. The basis for determination of the different components of the system. Scand. J. Clin. Lab. Invest. 31:1-86.
34. Nuovo, G. 1995. In situ PCR: protocols and applications. PCR Methods and Applications. 4:151s-167s.
35. Powell, S., G. Petersen, A. Krush, S. Booker, J. Jen, F. Giardiello, S. Hamilton, B. Vogelstein, and K. Kinzler. 1993. Molecular diagnosis of familial adenomatous polyposis. N. Engl J. Med. 329:1982-1987.
36. Singer-Sam, J., and A. Riggs. 1993. Quantitative analysis of messenger RNA levels: reverse transcription-polymerase chain reaction single nucleotide primer extension assay. Methods Enzymol. 225:344-351.
37. Wilcox, J. 1993. Fundamental principles of in situ hybridization. J. Histochem. Cytochem. 41:1725-1733.
38. Allen, T. 1994. Hematoxylin and Eosin. Lab. Meth. Histotech. 53-56.
39. Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques. 15:532-537.
40. Jeunemaitre, X., and J.-M. Lalouel. 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell. 71:169-180.
41. Rust, S., H. Funke, and G. Assmann. 1993. Mutagenically separated PCR (MS-PCR): a highly specific one step procedure for easy mutation detection. Nucl. Acids Res. 21:3623-3629.
42. Gaillard, I., E. Clauser, and P. Corvol. 1989. Structure of the human angiotensinogen gene. DNA (NY). 8:87-99.
43. Labarrere, C. and W. Faulk. 1994. Antigenic identification of cells in spiral artery trophoblastic invasion: Validation of histologic studies by triple-antibody immunohistochemistry. Am. J Obstet. Gynetol. 171:165-171.
44. Rosner, B. 1990. Fundamentals of Biostatistics. 3rd ed. M. Payne, editor. PWS-Kent, Boston, MA. 651.
45. Paul, M., J. Wagner, and V. Dzau. 1993. Gene expression of the renin-angiotensin system in human tissues. J. Clin. Invest. 91:2058-2064.
46. Pijnenborg, R., J. Bland, W. Robertson, and I. Brosens. 1983. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta. 4:397-414.
47. Tewksbury, D. 1983. Angiotensinogen. Fed. Proc. 42:2724-2728.
48. Menard, J., J. Bouhnik, E. Clauser, J. Richoux, and P. Corvol. 1983. Biochemistry and regulation of angiotensinogen. Clin. Exp. Hypertension. A5: 1005-1019.
49. Alhenc-Gelas, F., J. Richard, D. Courbon, J. Warnet, and P. Corvol. 1991. Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters. J. Lab. Clin. Med. 117:33-39.
50. Fukamizu, A., S. Takahashi, M.S. Seo, M. Tada, K. Takimoto, S. Uehara, and K. Murakami. 1990. Structure and expression of the human angiotensinogen gene. J. Biol. Chem. 265:7576-7582.
51. Perrot-Applanat, M., M. Deng, H. Fernandez, C. Lelaidier, G. Meduri, and P. Bouchard. 1994. Immunohistochemical localization of estradiol and progesterone receptors in human uterus throughout pregnancy: expression in endometrial blood vessels. J. Clin. Endocrinol. Metab. 78:216-224.
52. Yanai, K. 1996. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequence in human angiotensinogen gene. J. Biol. Chem. 271:15981-15986.
53. Takimolo, E., J. Ishida, F. Sugiyama, H. Horiguchi, K. Murakami, and A. Fukamizu. 1996. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science (Wash. DC). 274:995-997.
54. Ishigami, T. 1995. Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation. 91:951-954.
55. Tarnow, L., F. Cambien, P. Rossing, F. Nielsen, B. Hansen, S. Ricard. O. Poirier, and H.-H. Parving. 1996. Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes. 45:367-369.